UNSPSC 51294801: Gepirone

This classification denotes a serotonin agonist and anxiolytic with the molecular formula C19H29N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JW5Y7B8Z18, chemically known as 3,3-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)glutarimide monohydrochloride but generally known as gepirone, which bears US NIH Compound Identifier 55190. European Medicines Agency schedules Gepirone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07897MIG.

UNSPSC 51294801 Gepirone, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS—solicits naloxone and safe drug deactivation systems for community health support, a pharmaceutical and harm-reduction product category distinct from gepirone, an antidepressant medication. State and local procurement records show minimal or misaligned activity under this code, limiting visibility into actual buying patterns for gepirone itself. Without representative solicitations for gepirone procurement at the state and local level, the practical scope of work, issuing-body patterns, and geographic concentration cannot be meaningfully characterized from current activity.

The mismatch between the code's nominal pharmaceutical category and the naloxone-focused opportunity suggests either a tagging error in the state and local data source or limited gepirone procurement activity through traditional UNSPSC-classified state and local channels. Health agencies, pharmaceutical purchasing cooperatives, and state Medicaid programs would typically buy gepirone through bulk purchasing agreements or standing orders rather than competitive sealed bids, which may explain the absence of solicitations matching the code's intended scope. Business development professionals evaluating this code should treat the recent opportunity record as insufficient to support go-forward pursuit decisions and supplement research with direct outreach to state health departments, corrections departments, and mental-health-focused procurement offices to assess actual demand for gepirone products at the state and local level.